US Patent Issued to INSTITUT CURIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) on July 29 for "Immune cells defective for SUV39H1" (French, Italian Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,471, issued on July 29, was assigned to INSTITUT CURIE (Paris), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (Paris) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (Paris).

"Immune cells defective for SUV39H1" was invented by Sebastian Amigorena (Paris), Eliane Piaggio (Paris), Christel Goudot (Le Blanc Mesnil, France), Luigia Pace (Turin, Italy), Genevieve Almouzni (Neuilly sur Seine, France) and Leticia Niborski (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an engineered immune cell defective for Suv39h1. Preferably, said engineered immune cell further comprises a genetically ...